Rationale and application of immunotherapy for human cancer
- 31 May 1978
- journal article
- Published by Elsevier in Current Problems in Cancer
- Vol. 2 (11) , 1-75
- https://doi.org/10.1016/s0147-0272(78)80009-9
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.BMJ, 1976
- Skeletal and soft tissue sarcomas. Treatment with adjuvant immunotherapyJAMA, 1976
- THERAPEUTIC EFFECTIVENESS OF NEURAMINIDASE‐TREATED TUMOR CELLS AS AN IMMUNOGEN IN MAN AND EXPERIMENTAL ANIMALS WITH LEUKEMIA*Annals of the New York Academy of Sciences, 1976
- Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regressionClinical Immunology and Immunopathology, 1976
- Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant propertiesMolecular and Cellular Biochemistry, 1975
- Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemiaPublished by Elsevier ,1974
- Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. ParvumInternational Journal of Cancer, 1974
- Restoration of host defense mechanisms in man by levamisoleLife Sciences, 1973
- Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCGScience, 1971
- Cancer Immunity—Hypothesis and Clinical Trial of Lymphocytotherapy for Malignant DiseasesAnnals of Surgery, 1970